These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


342 related items for PubMed ID: 17398178

  • 21. Major vascular events after transient ischaemic attack and minor ischaemic stroke: post hoc modelling of incidence dynamics.
    Atanassova PA, Chalakova NT, Dimitrov BD.
    Cerebrovasc Dis; 2008; 25(3):225-33. PubMed ID: 18216464
    [Abstract] [Full Text] [Related]

  • 22. Homocysteine and outcome in young patients with acute coronary syndromes.
    Martín-Herrero F, Martín-Moreiras J, Pabón P, Sánchez PL, Moríñigo-Muñoz JL, Jimenez-Candil J, Cruz-González I, Alberca I, González-Porras JR, Martín-Luengo C.
    Int J Cardiol; 2007 May 31; 118(2):183-8. PubMed ID: 17023077
    [Abstract] [Full Text] [Related]

  • 23. Serum gamma-glutamyl transferase activity: new high-risk criteria in acute coronary syndrome patients?
    Ulus T, Yildirir A, Sade LE, Temiz A, Polat E, Bozbaş H, Aydinalp A, Eroğlu S, Ozin B, Müderrisoğlu H.
    Coron Artery Dis; 2008 Nov 31; 19(7):489-95. PubMed ID: 18923245
    [Abstract] [Full Text] [Related]

  • 24. ST-segment deviation on the admission electrocardiogram, treatment strategy, and outcome in non-ST-elevation acute coronary syndromes A substudy of the Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) Trial.
    Windhausen F, Hirsch A, Tijssen JG, Cornel JH, Verheugt FW, Klees MI, de Winter RJ, Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) investigators.
    J Electrocardiol; 2007 Nov 31; 40(5):408-15. PubMed ID: 17604045
    [Abstract] [Full Text] [Related]

  • 25. Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged men.
    Muscari A, Massarelli G, Bastagli L, Poggiopollini G, Tomassetti V, Drago G, Martignani C, Pacilli P, Boni P, Puddu P.
    Eur Heart J; 2000 Jul 31; 21(13):1081-90. PubMed ID: 10843826
    [Abstract] [Full Text] [Related]

  • 26. Effects of C-reactive protein and the third and fourth components of complement (C3 and C4) on incidence of atrial fibrillation.
    Dernellis J, Panaretou M.
    Am J Cardiol; 2006 Jan 15; 97(2):245-8. PubMed ID: 16442371
    [Abstract] [Full Text] [Related]

  • 27. Soluble CXCL16 predicts long-term mortality in acute coronary syndromes.
    Jansson AM, Aukrust P, Ueland T, Smith C, Omland T, Hartford M, Caidahl K.
    Circulation; 2009 Jun 30; 119(25):3181-8. PubMed ID: 19528340
    [Abstract] [Full Text] [Related]

  • 28. Impact of metabolic syndrome on future cardiovascular events in patients with first acute myocardial infarction.
    Selcuk H, Temizhan A, Selcuk MT, Sen T, Maden O, Tekeli S, Sasmaz A.
    Coron Artery Dis; 2009 Sep 30; 20(6):370-5. PubMed ID: 19609207
    [Abstract] [Full Text] [Related]

  • 29. Depression, C-reactive protein and two-year major adverse cardiac events in men after acute coronary syndromes.
    Frasure-Smith N, Lespérance F, Irwin MR, Sauvé C, Lespérance J, Théroux P.
    Biol Psychiatry; 2007 Aug 15; 62(4):302-8. PubMed ID: 17210140
    [Abstract] [Full Text] [Related]

  • 30. Immune response in acute coronary syndromes.
    Jan V, Jalal S, Aslam K, Iqbal K, Tramboo N, Alai MS, Rather H, Lone N.
    Indian Heart J; 1999 Aug 15; 51(5):515-20. PubMed ID: 10721642
    [Abstract] [Full Text] [Related]

  • 31. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels.
    Hong SN, Ahn Y, Yoon NS, Lee KH, Kim YS, Hwang SH, Lee SR, Kim KH, Park HW, Hong YJ, Kim JH, Jeong MH, Cho JG, Park JC, Kang JC.
    Am J Cardiol; 2007 Apr 15; 99(8):1051-4. PubMed ID: 17437726
    [Abstract] [Full Text] [Related]

  • 32. Predischarge C-reactive protein and 1-year outcome after acute coronary syndromes.
    Steg PG, Ravaud P, Tedgui A, Puel J, Moyse D, Curaudeau E, Quentzel SW, ELISCOR Investigators.
    Am J Med; 2006 Aug 15; 119(8):684-92. PubMed ID: 16887415
    [Abstract] [Full Text] [Related]

  • 33. Changes in plasma levels of complement in patients with acute ischemic stroke.
    Cojocaru IM, Cojocaru M, Tănăsescu R, Burcin C, Atanasiu AN, Petrescu AM, Mitu AC, Iliescu I, Dumitrescu L.
    Rom J Intern Med; 2008 Aug 15; 46(1):77-80. PubMed ID: 19157274
    [Abstract] [Full Text] [Related]

  • 34. Atherosclerotic risk genotypes and recurrent coronary events after myocardial infarction.
    Moss AJ, Ryan D, Oakes D, Goldstein RE, Greenberg H, Bodenheimer MM, Brown MW, Case RB, Dwyer EM, Eberly SW, Francis CW, Gillespie JA, Krone RJ, Lichstein E, MacCluer JW, Marcus FI, McCarthy J, Sparks CE, Zareba W.
    Am J Cardiol; 2005 Jul 15; 96(2):177-82. PubMed ID: 16018837
    [Abstract] [Full Text] [Related]

  • 35. Serum albumin predicts cardiac adverse events in patients with advanced atherosclerosis - interrelation with traditional cardiovascular risk factors.
    Schillinger M, Exner M, Mlekusch W, Amighi J, Sabeti S, Schlager O, Wagner O, Minar E.
    Thromb Haemost; 2004 Mar 15; 91(3):610-8. PubMed ID: 14983239
    [Abstract] [Full Text] [Related]

  • 36. Renal dysfunction in acute stroke: an independent predictor of long-term all combined vascular events and overall mortality.
    Tsagalis G, Akrivos T, Alevizaki M, Manios E, Stamatellopoulos K, Laggouranis A, Vemmos KN.
    Nephrol Dial Transplant; 2009 Jan 15; 24(1):194-200. PubMed ID: 18728156
    [Abstract] [Full Text] [Related]

  • 37. Plasma lipoprotein(a) concentration predicts future coronary and cardiovascular events in patients with stable coronary heart disease.
    Nestel PJ, Barnes EH, Tonkin AM, Simes J, Fournier M, White HD, Colquhoun DM, Blankenberg S, Sullivan DR.
    Arterioscler Thromb Vasc Biol; 2013 Dec 15; 33(12):2902-8. PubMed ID: 24092750
    [Abstract] [Full Text] [Related]

  • 38. Markers of eosinophilic inflammation and risk prediction in patients with coronary artery disease.
    Falcone C, Minoretti P, D'Angelo A, Buzzi MP, Coen E, Emanuele E, Aldeghi A, Olivieri V, Geroldi D.
    Eur J Clin Invest; 2006 Apr 15; 36(4):211-7. PubMed ID: 16620281
    [Abstract] [Full Text] [Related]

  • 39. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.
    Omland T, Sabatine MS, Jablonski KA, Rice MM, Hsia J, Wergeland R, Landaas S, Rouleau JL, Domanski MJ, Hall C, Pfeffer MA, Braunwald E, PEACE Investigators.
    J Am Coll Cardiol; 2007 Jul 17; 50(3):205-14. PubMed ID: 17631211
    [Abstract] [Full Text] [Related]

  • 40. Inflammatory and anti-inflammatory variable clusters and risk prediction in acute coronary syndrome patients: a factor analysis approach.
    Tziakas DN, Chalikias GK, Kaski JC, Kekes A, Hatzinikolaou EI, Stakos DA, Tentes IK, Kortsaris AX, Hatseras DI.
    Atherosclerosis; 2007 Jul 17; 193(1):196-203. PubMed ID: 16857204
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 18.